Early Intensification with Abacavir in Subjects at High Risk for Incomplete Viral Suppression

Bartlett J.A. , Demasi R. , Quinn J.B. , Moxham C. , & Rousseau F. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS 2002; 15: 1369–1377.

Hammer S.M. , Squires K.E. , Hughes M.D. , Grimes J.M. , Demeter L.M. , Currier J.S. , Eron J.J. Jr. , Feinberg J.E. , Balfour H.H. Jr. , Deyton L.R. , Chodakewitz J.A. , & Fischl M.A. A controlled trial of two nucleoside analogues plus indinavir in persons with HIV infection and CD4 cell counts of 200 per cubic millimeter or less. New England Journal of Medicine 1997; 337: 725–733.

Havlir D.V. , Marschner I.C. , Hirsch M.S. , Collier A.C. , Tebas P. , Bassett R.L. , Ioannidis J.P. , Holohan M.K. , Leavitt R. , Boone G. , & Richman D.D. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple drug therapy. New England Journal of Medicine 1998; 339: 1261–1268.

Rozenbaum W. , Katlama C. , Massip P. , Bentata M. , Zucman D. , Delfraissy J.F. , Trepo C. , David F. , Lanier E.R. , Vavro C. , & Mamet J.P. Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment. Antiviral Therapy 2001; 6: 135–142.

Fischl M.A. , Greenberg S. , Clumeck N. , Peters B. , Rubio R. , Pobiner B. , & Verity L. Safety and activity of abacavir with 3TC/ZDV in antiretroviral-naive subjects. Abstract 127, presented at the 12th World AIDS Conference; Geneva, Switzerland, 1998.

Gisolf E.H. , Jurriaans S. , Pelgrom J. , van Wanzeele F. , van der Ende M.E. , Brinkman K. , Borst M.J. , de Wolf F. , Japour A.J. , & Danner S.A. The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. AIDS 2000; 14: 405–413.

Walmsley S. , Bernstein B. , King M. , Arribas J. , Beall G. , Ruane P. , Johnson M. , Johnson D. , Lalonde R. , Japour A. , Brun S. , & Sun E ; M98-863 Study Team. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. New England Journal of Medicine 2002; 346: 2039–2046.

Staszewski S. , Gallant J. , Pozniak A. , Suleiman J.M.A.H. , DeJesus E. , Lu B. , Sayre J. , & Cheng A. Efficacy and safety of tenofovir versus stavudine when used in combination with lamivudine and efavirenz in HIV-1 infected patient naïve to antiretroviral therapy: 48 week interim results. Abstract LB0-17, presented at the 14th World AIDS Conference; Barcelona, Spain, 2002.

Robbins G. , Shafer R. , Smeaton L. . Antiretroviral strategies in naive HIV+ subjects: Comparison of 4-drug versus sequential 3-drug regimens (ACTG 384). Abstract LB0-20B, presented at the 14th World AIDS Conference; Barcelona, Spain, 2002.